POSTER: IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)

Autor:	Nastoupil, Loretta J., Dahiya, Saurabh, Palomba, M. Lia, Garcia-Sancho, Alejandro Martin, Ortega, Juan Luis Reguera, Kuruvilla, John, Jager, Ulrich, Cartron, Guillaume, Izutsu, Koji Izutsu, Dreyling, Martin, Kahl, Brad, Ghesquieres, Hervé, Ardeshna, Kirit, Goto, Hideki, Barbui, Anna Maria, Abramson, Jeremy S., Borchmann, Peter, Fleury, Isabelle, Mielke, Stephan, Farazi, Thalia, Fasan, Omotayo, Lymp, James, Vedal, Min, Nishii, Rina, Avilion, Ariel, Papuga, Jessica, Morschhauser, Frank
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S209-S209
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect